• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EHD2 过表达抑制人结肠癌细胞的增殖、迁移和侵袭。

EHD2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Human Colon Cancer.

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.

出版信息

Cancer Invest. 2021 Apr;39(4):297-309. doi: 10.1080/07357907.2020.1870125. Epub 2021 Jan 8.

DOI:10.1080/07357907.2020.1870125
PMID:33356637
Abstract

To investigate how EHD2 influences the development of colon cancer. Immunohistochemistry of 90 colon cancer tissue specimens were determined the expression of EHD2. The lentivirus-EHD2-transfected colon cancer cells were conducted to evaluate the biological behaviors. EHD2 was closely associated with clinic pathological parameters ( < 0.001). EHD2 upregulation was relative with a longer overall survival. The results of the univariate and multivariate analyses indicated that EHD2 could be an independent prognosis marker. EHD2 overexpression suppressed cell invasion and proliferation, but enhanced cell apoptosis and cell cycle arrest. EHD2 might represent a therapeutic target of colon cancer.IMPACT STATEMENT Membrane trafficking is crucial for cell proliferation, differentiation and apoptosis, especially tumorigenesis and development. EHD2 proteins play an important role in the regulation of membrane trafficking in endocytosis. EHD2 has been suggested to participate in the occurrence of some malignancies. EHD2 could be an independent prognosis marker in colon cancer. EHD2 overexpression suppressed cell invasion and proliferation, but enhanced cell apoptosis and cell cycle arrest . EHD2 overexpression markedly increased the expression of EMT marker E-cadherin in colon cancer. EHD2 overexpression may inhibit tumorigenesis in colon cancer through the modulation of E-cadherin, the critical marker of EMT which is closely related to invasion and distant metastasis of tumor cells.

摘要

为了研究 EHD2 如何影响结肠癌的发展。通过免疫组织化学方法检测 90 例结肠癌组织标本中 EHD2 的表达情况。转染 EHD2 的慢病毒结肠癌细胞系被用来评估其生物学行为。EHD2 与临床病理参数密切相关(<0.001)。EHD2 上调与总生存期延长相关。单因素和多因素分析结果表明,EHD2 可以作为独立的预后标志物。EHD2 过表达抑制细胞侵袭和增殖,但增强细胞凋亡和细胞周期阻滞。EHD2 可能代表结肠癌的治疗靶点。

意义陈述

膜转运对于细胞增殖、分化和凋亡,特别是肿瘤的发生和发展至关重要。EHD2 蛋白在细胞内吞作用中对膜转运的调节中发挥重要作用。EHD2 被认为参与了一些恶性肿瘤的发生。EHD2 可以作为结肠癌的独立预后标志物。EHD2 过表达抑制细胞侵袭和增殖,但增强细胞凋亡和细胞周期阻滞。EHD2 过表达显著增加了结肠癌中 EMT 标志物 E-钙黏蛋白的表达。EHD2 过表达可能通过调节 EMT 的关键标志物 E-钙黏蛋白来抑制结肠癌的肿瘤发生,E-钙黏蛋白与肿瘤细胞的侵袭和远处转移密切相关。

相似文献

1
EHD2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Human Colon Cancer.EHD2 过表达抑制人结肠癌细胞的增殖、迁移和侵袭。
Cancer Invest. 2021 Apr;39(4):297-309. doi: 10.1080/07357907.2020.1870125. Epub 2021 Jan 8.
2
Numb inhibits migration and promotes proliferation of colon cancer cells via RhoA/ROCK signaling pathway repression.麻木通过抑制 RhoA/ROCK 信号通路抑制结肠癌细胞的迁移和增殖。
Exp Cell Res. 2022 Feb 15;411(2):113004. doi: 10.1016/j.yexcr.2021.113004. Epub 2022 Jan 3.
3
miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.微小RNA-378通过抑制SDAD1抑制结肠癌细胞的增殖、迁移和侵袭。
Cell Mol Biol Lett. 2017 Jul 17;22:12. doi: 10.1186/s11658-017-0041-5. eCollection 2017.
4
Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.肝细胞核因子4α抑制结肠癌的恶化。
Mol Carcinog. 2016 May;55(5):458-72. doi: 10.1002/mc.22294. Epub 2015 Mar 25.
5
Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway.NPRL2 过表达通过激活 DNA 损伤检查点通路增强结肠癌细胞对伊立替康(CPT-11)的敏感性。
Med Sci Monit. 2018 Mar 9;24:1424-1433. doi: 10.12659/msm.909186.
6
Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.EHD2表达降低促进肝癌转移并提示预后不良。
Dig Dis Sci. 2016 Sep;61(9):2554-67. doi: 10.1007/s10620-016-4202-6. Epub 2016 May 25.
7
Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.地塞米松抑制结肠癌中缺氧诱导的上皮-间质转化。
World J Gastroenterol. 2015 Sep 14;21(34):9887-99. doi: 10.3748/wjg.v21.i34.9887.
8
Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.GNL3表达上调通过Wnt/β-连环蛋白信号通路促进结肠癌细胞的增殖、迁移、侵袭及上皮-间质转化。
Oncol Rep. 2017 Oct;38(4):2023-2032. doi: 10.3892/or.2017.5923. Epub 2017 Aug 25.
9
Role of EHD2 in migration and invasion of human breast cancer cells.EHD2在人乳腺癌细胞迁移和侵袭中的作用。
Tumour Biol. 2015 May;36(5):3717-26. doi: 10.1007/s13277-014-3011-9. Epub 2015 Jan 5.
10
The oncogenic role of NKAP in the growth and invasion of colon cancer cells.NKAP 在结肠癌细胞生长和侵袭中的致癌作用。
Oncol Rep. 2019 Nov;42(5):2130-2138. doi: 10.3892/or.2019.7322. Epub 2019 Sep 18.

引用本文的文献

1
and colorectal cancer: A paradoxical role revealed through metabolite profiling and prognostic modeling.与结直肠癌:通过代谢物谱分析和预后模型揭示的矛盾作用。
World J Clin Oncol. 2025 Apr 24;16(4):104182. doi: 10.5306/wjco.v16.i4.104182.
2
EHD2, a novel HIF target gene, is a promising biomarker in clear cell renal cell carcinoma.EHD2是一种新的缺氧诱导因子(HIF)靶基因,是透明细胞肾细胞癌中有前景的生物标志物。
Int J Clin Exp Pathol. 2023 Nov 15;16(11):344-351. eCollection 2023.
3
Endocytosis in cancer and cancer therapy.癌症和癌症治疗中的内吞作用。
Nat Rev Cancer. 2023 Jul;23(7):450-473. doi: 10.1038/s41568-023-00574-6. Epub 2023 May 22.
4
EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry.EHD2 过表达通过调节钙库操纵性钙内流促进三阴性乳腺癌的发生和转移。
Elife. 2023 Jan 10;12:e81288. doi: 10.7554/eLife.81288.
5
inhibits the invasive ability of lung adenocarcinoma and improves the prognosis of patients.抑制肺腺癌的侵袭能力并改善患者的预后。
J Thorac Dis. 2022 Jul;14(7):2652-2664. doi: 10.21037/jtd-22-842.